Company Overview and News
U.S. Silica Holdings, Inc. (SLCA - Free Report) is set to release first-quarter 2018 results before the opening bell on Apr 24. In the last reported quarter, the company delivered a negative earnings surprise of 7.3% by posting adjusted earnings of 51 cents per share, which trailed the Zacks Consensus Estimate of 55 cents. However, revenues for the quarter witnessed a 98% year-over-year surge to $360.
WEST CHESTER, Ohio, April 11, 2018 (GLOBE NEWSWIRE) -- AK Steel (NYSE:AKS) said today that three of its employees were recognized by the Manufacturing Institute as 2018 STEP Ahead Award winners who exemplify leadership in Science, Technology, Engineering and Production. Lisa A. Vensel, AK Steel General Manager, Manufacturing Planning and Joyce C. Niedringhaus, AK Steel Principal Research Engineer, were named 2018 STEP Ahead Honorees.
China is avenging President Donald Trump’s tariffs worth $60 billion on steel, aluminum and other products by imposing import duties on as many as 128 U.S. items including agricultural products, pork and fruits. Undoubtedly, the tariffs imposed by China’s Ministry of Finance, effective Monday, heightened fears of an ensuing trade war.
Much to the respite of American steel makers, U.S. steel imports have dropped roughly 5% year to date – according to the latest report from the American Iron and Steel Institute (AISI), an association of North American steel makers. Per AISI, based on preliminary U.S. Census Bureau data, total domestic steel imports went down 18% on a monthly comparison to roughly 2.36 million net tons in February.
President Donald Trump, on Mar 8, signed proclamations imposing steep tariffs on steel and aluminum imports in a major move to protect the domestic producers of these metals, rebuild the long-struggling U.S. steel and aluminum industries and safeguard American jobs. The highly controversial tariffs, which the President believes are necessary to protect national security, are set to go into effect today.
U.S. equities are in a bad place on Thursday, gapping lower at the open and continuing to slide into the afternoon. Investors have a number of reasons to be spooked, including the announcement of $50 billion in trade tariffs by President Trump, the lingering hawkishness of the Federal Reserve’s policy announcement on Wednesday and the ongoing fallout from Facebook Inc’s (NASDAQ:FB) data privacy missteps as well as the impact it’s having on the entire tech sector.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
WEST CHESTER, Ohio, March 20, 2018 (GLOBE NEWSWIRE) -- AK Steel (NYSE:AKS) said today that it plans to release its first quarter 2018 financial results before the opening of trading on the New York Stock Exchange on Monday, April 30, 2018.
Stocks took a hit lower on Monday, but the major indices were looking slightly positive on Tuesday. The bull market is now over nine years old, and investors are still considering how they want to be positioned for the rest of 2018 and beyond. One trend that has kept working is for investors to buy all the big pullbacks.
Tesla Inc. shares slid 1.6% in premarket trade Monday, after Goldman Sachs reiterated its sell rating on the stock and said quarter-to-date datapoints suggest the company's first-quarter deliveries will be disappointing. "We believe the company is tracking below its 2018 Model S/X guidance of approx. 100k units (an implied 25,000 per quarter)," analysts led by David Tamberrino wrote in a note. "Further, while monthly Model 3 deliveries are showing sequential improvement, we estimate that they will fall well short of consensus expectations.
AK Steel Holding Corporation (AKS - Free Report) reached a two-year labor agreement with the members of the International Association of Machinists and Aerospace Workers (“IAM”) Local 1943. The deal, covering roughly 1,730 hourly employees at the company’s Middletown, OH facility will be effective until Mar 15, 2020. The contract was ratified via voting on Mar 12 and the company is said to have reached the agreement ahead of the expiration date.
2017-10-23 - Asif
AK Steel Holding is the only steelmaker in North America that can produce all three major categories of flat-rolled steels—namely carbon, stainless and electrical. In addition, the company is the only domestic producer of flat-rolled steels that operates both blast furnaces and electric arc furnaces, providing it operational flexibility and the opportunity to innovate across markets and within its product portfolios. AK Steel operate eight steelmaking and finishing plants, two coke plants, a metallurgical coal production facility and two tube manufacturing plants across six states (Indiana, Kentucky, Michigan, Ohio, Pennsylvania and West Virginia) and a tube manufacturing plant in Mexico. These operations produce flat-rolled carbon steels, including premium-quality coated, cold-rolled and hot-rolled carbon steel products, and specialty stainless and electrical steels that the company sell in sheet and strip form, as well as carbon and stainless steel that the company manufacture into w...
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET